As the hypoxia-mediated deregulation of TET methylcytosine dioxygenase 1 (TET1) and TET3 has been shown to promote breast cancer TIC properties, such hypoxia-induced alterations of epigenetic controls can be considered as an important driving force of malignant tumor progression [50]. This evidence concerns the gene TET1 and breast cancer.